Janumet
Product Images NDC 50090-4411

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Janumet (NDC 50090-4411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Sitagliptin Chemical Structure (Janumetxr 01)

Chemical structure of the active ingredient in JANUMET XR, showing molecular components including a trifluoromethyl group, a piperazine ring, and associated phosphate and water molecules.*

FDA Label Image

Image Of Metaformin Chemical Structure (Janumetxr 02)

Chemical structure of the active ingredient in JANUMET XR, displaying a molecular formula with methyl groups, amine groups, and a hydrochloride component.*

FDA Label Image

Image Of Figure 1 (Janumetxr 03)

A line graph showing least squares mean change from baseline over 24 weeks for different treatment groups in a clinical study. The x-axis represents weeks (0 to 24), and the y-axis shows change from baseline. Treatment groups include Placebo, Sitagliptin 100 mg once daily, Metformin Immediate-Release 500 mg twice daily, Metformin Immediate-Release 1000 mg twice daily, Sitagliptin 50 mg twice daily combined with Metformin Immediate-Release 500 mg twice daily, and Sitagliptin 50 mg twice daily combined with Metformin Immediate-Release 1000 mg twice daily.*

FDA Label Image

Image Of Figure 2 (Janumetxr 04)

Line graph showing the least squares mean change from baseline over 52 weeks comparing Sitagliptin 100 mg and Glipizide. The x-axis represents time in weeks, and the y-axis represents the LS mean change from baseline, with both treatments showing a decrease followed by a slight increase towards the end of the period.*

FDA Label Image

Label Image (Lbl500904411)

JANUMET XR label from A-S Medication Solutions displaying the product name, NDC 50090-4411-0, dosage strength of 50 mg/100 mg as extended-release tablets, storage instructions to keep between 68 to 77 degrees Fahrenheit in a dry place, and packaging details for 90 extended-release tablets per container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.